Suanfarma Biotech engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. It offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. Suanfarma Biotech also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, it invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. Suanfarma Biotech serves customers in Spain and internationally. It began operation in 1993, with its headquarters in Alcobendas in Spain and locations in Phoenix in Arizona, Fair Lawn in New Jersey, Naucalpan de Juárez in Mexico; Bogotá in Colombia, Caracas in Venezuela, Sao Paulo in Brazil, Buenos Aires in Argentina, Santiago in Chile, Madrid and Barcelona in Spain, Fitbourg in Switzerland, Dubai in the United Arab Emirates, Navi Mumbai in India, and Shanghai in China.

Total investments

1

Lead investments

0

Investments · 12mo

0

Active investors

0